Barclays’s BrightSpring Health Services Unit BTSGU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$142K Sell
1,000
-31,816
-97% -$4.3M ﹤0.01% 3876
2025
Q4
$4.14M Hold
32,816
﹤0.01% 2363
2025
Q3
$3.32M Hold
32,816
﹤0.01% 2499
2025
Q2
$2.71M Buy
32,816
+797
+2% +$58.9K ﹤0.01% 2610
2025
Q1
$2.08M Sell
32,019
-996
-3% -$70.4K ﹤0.01% 2601
2024
Q4
$2.07M Hold
33,015
﹤0.01% 2848
2024
Q3
$1.84M Hold
33,015
﹤0.01% 2917
2024
Q2
$1.55M Sell
33,015
-1,985
-6% -$88.2K ﹤0.01% 2312
2024
Q1
$1.55M Buy
+35,000
New +$1.46M ﹤0.01% 2776

Other funds holding BTSGU

Barclays's BTSGU Position: Q1 2026 in Review

Barclays reduced its BrightSpring Health Services Unit (BTSGU) stake by 97% in Q1 2026, selling an estimated $4.3M and leaving 1,000 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #3876.

Barclays first reported a position in BTSGU in Q1 2024 and has held it in 9 quarters since. The position peaked at $4.14M in Q4 2025. 30 funds tracked by Wall St. Rank hold BTSGU as of Q1 2026.

  • Barclays held 1,000 shares of BrightSpring Health Services Unit worth $142K as of Q1 2026.
  • Barclays sold 31,816 BrightSpring Health Services Unit shares in Q1 2026, an estimated $4.3M.
  • BrightSpring Health Services Unit made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3876 holding.
  • Barclays first reported a position in BrightSpring Health Services Unit in Q1 2024 and has held it in 9 quarters since.
  • Barclays's BrightSpring Health Services Unit position peaked at $4.14M in Q4 2025.
  • 30 funds tracked by Wall St. Rank held BrightSpring Health Services Unit as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.